Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.

Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.

Item
http://www.wikidata.org/entity/Q31956898
Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.Fractionated stereotactic radiotherapy boost and weekly paclitaxel in malignant gliomas clinical and pharmacokinetics results.Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database.Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastomaRadiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.Advantages of a unique DNA-based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in mice.Early toxicity predicts long-term survival in high-grade glioma.Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study.Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.Selection of chemotherapy for glioblastoma expressing O(6)-methylguanine-DNA methyltransferaseEnhancing radiation therapy for patients with glioblastoma.Combined modality approaches in the management of adult glioblastoma.In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy.
P2860

Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.

Item
http://www.wikidata.org/entity/Q31956898
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Phase II radiation therapy onc ...... orial glioblastoma multiforme.
@ast
Phase II radiation therapy onc ...... orial glioblastoma multiforme.
@en
type
label
Phase II radiation therapy onc ...... orial glioblastoma multiforme.
@ast
Phase II radiation therapy onc ...... orial glioblastoma multiforme.
@en
prefLabel
Phase II radiation therapy onc ...... orial glioblastoma multiforme.
@ast
Phase II radiation therapy onc ...... orial glioblastoma multiforme.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Phase II radiation therapy onc ...... orial glioblastoma multiforme.
@en
P2093
P304
P31
P356
10.1016/S0360-3016(01)01597-8
P407
P433
P478
P577
P698
P921